Rentschler Biopharma is establishing a Center of Excellence for cell and gene therapy, which will be located in Stevenage, UK With the newly formed U.K. subsidiary, Rentschler ATMP, the CDMO will establish development and manufacturing capability in ATMPs. Source: Genetic Engineering News 12/2/2021